ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 146 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,806,038 | -16.2% | 185,751 | -18.7% | 0.01% | -16.7% |
| Q2 2023 | $4,539,321 | -31.1% | 228,451 | -40.6% | 0.01% | -29.4% |
| Q1 2023 | $6,589,072 | -24.8% | 384,651 | -14.1% | 0.02% | -29.2% |
| Q4 2022 | $8,764,444 | +27.3% | 447,851 | +3.8% | 0.02% | +20.0% |
| Q3 2022 | $6,886,000 | +41.9% | 431,451 | +22.3% | 0.02% | +42.9% |
| Q2 2022 | $4,852,000 | +11.7% | 352,651 | +28.8% | 0.01% | +16.7% |
| Q1 2022 | $4,343,000 | -8.2% | 273,851 | +26.4% | 0.01% | 0.0% |
| Q4 2021 | $4,729,000 | -18.6% | 216,651 | +11.4% | 0.01% | -20.0% |
| Q3 2021 | $5,812,000 | -25.5% | 194,451 | +10.5% | 0.02% | -28.6% |
| Q2 2021 | $7,797,000 | -4.1% | 176,051 | -3.9% | 0.02% | -4.5% |
| Q1 2021 | $8,131,000 | +322.6% | 183,251 | +422.4% | 0.02% | +340.0% |
| Q4 2020 | $1,924,000 | +401.0% | 35,076 | +108.7% | 0.01% | +400.0% |
| Q3 2020 | $384,000 | +24.7% | 16,806 | +14.3% | 0.00% | 0.0% |
| Q2 2020 | $308,000 | +45.3% | 14,706 | +71.0% | 0.00% | 0.0% |
| Q3 2018 | $212,000 | – | 8,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |